April 22, 2019
University of California San Diego School of Medicine researchers found that treating patients with personalized precision medicine that combined therapies to target multiple alterations improved outcomes in patients with therapy resistant cancers.
August 17, 2020
The multiplication of genes located in extrachromosomal DNA that have the potential to cause cancer drives poor patient outcomes across many cancer types, according to a Nature Genetics study published Aug. 17, 2020 by a team of researchers including the University of California San Diego.
March 16, 2020
Research and Development (R&D) has long been key in the U.S.’s economic prospects and according to new research from the University of California San Diego, the country’s ability to maintain its competitive edge in this area largely depends on managers in R&D being less averse to risk.
June 22, 2021
Longtime supporters of cancer research and patient care at Moores Cancer Center at UC San Diego Health have given University of California San Diego School of Medicine $2 million to establish the Iris and Matthew Strauss Chancellor’s Endowed Chair in Head and Neck Surgery.
January 10, 2020
UC San Diego School of Medicine researchers have discovered how a new immune system works to protect bacteria from phages, viruses that infect bacteria — new information that could be leveraged to improve treatment of multidrug-resistant bacterial infections by refining phage therapy.
February 15, 2019
The Next Generation Precision Oncology Symposium, a novel meeting of industry and academic leaders in cancer science and medicine, will be held February 21, 2019 at UC San Diego Moores Cancer Center.
October 26, 2021
University of California San Diego researchers describe how a pair of fundamental genetic and cellular processes — aneuploidy and unfolded protein response — are exploited by cancer cells to promote tumor survival and growth.
January 13, 2020
University of California San Diego School of Medicine researchers identified how THC from marijuana accelerates cancer growth in patients with human papillomavirus (HPV)-positive head and neck cancer.
May 10, 2018
…a particular type of immunotherapy that is used for other types of cancers, but is not standard treatment for basal cell carcinoma. They believed the drug would help Lyon because previous studies suggested it was effective against other cancers with genetic mutations similar to his. It worked. Today, Lyon’s tumors…
October 4, 2016
Four biologists, a nanoengineer and a biophysicist at UC San Diego today received a total of more than $5 million in grants from the National Institutes of Health to pursue innovative and transformative research projects.
